Posted by Defense World Staff on Feb 27th, 2026
Palvella Therapeutics, Inc. (NASDAQ:PVLA – Free Report) – Research analysts at HC Wainwright raised their FY2027 earnings estimates for shares of Palvella Therapeutics in a research report issued on Tuesday, February 24th....
More of this article »